Cannabis
Trump Hints at Cannabis Rescheduling as Opioid Crisis Deepens
In a strategic development that could reshape the United States’ drug policy, President Donald Trump has confirmed that his administration is “looking very strongly” at rescheduling cannabis from a Schedule I to a Schedule III controlled substance. Speaking from the…
New PM2 Gene Discovery by Aurora Cannabis Enhances Disease Resistance
Cannabis Growth Cannabis has been a booming industry in the USA and many other countries in the past decade. This followed a slow, but steady trend toward full legalization, even if doing so at the US federal level of what…
Jonathan Schramm
Selective Banking Practices Remain Prevalent Despite the Expected Easing of Restrictions on the Cannabis Industry
Any connection between banks and the financial industry with cannabis businesses poses legal and regulatory risks. The cannabis industry still faces significant banking challenges, leading most transactions to be conducted in cash, which makes these businesses prime targets for robberies…
Discovering and Enhancing Use-Cases for Cannabis
As acceptance of Cannabis has grown over the past few years, so has our understanding of the medication/drug. Despite this, researchers believe that many beneficial but untapped effects of the medication have yet to be discovered. This has resulted in…
Top 10 Cannabis Stocks in a Growing Market (October 2026)
Sin Stocks Outperformance Sin stocks are a category of stocks from companies involved in what is considered “immoral” activities, like gambling, alcohol, tobacco, or weapons manufacturing. Many investment funds and individuals will refuse to invest in these sectors, causing an…
Jonathan Schramm
